ADVERTISEMENT
Opinion: Emergency Use Authorizations Are a Threat to Science<strong>&nbsp;</strong>
Opinion: Emergency Use Authorizations Are a Threat to Science 
As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.
Opinion: Emergency Use Authorizations Are a Threat to Science 
Opinion: Emergency Use Authorizations Are a Threat to Science 

As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.

As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.

regulation, disease & medicine, policy

WHO Panel Calls For a Registry of Gene-Editing Research in Humans
Catherine Offord | Mar 20, 2019 | 2 min read
The advisors’ recommendations follow news of ethically dubious gene-editing work carried out by He Jiankui late last year.
cans of food, seen from the top
A Landmark Study On BPA Leaves Scientists at Odds
Shawna Williams | Oct 26, 2018 | 6 min read
Conceived as a way to resolve differences between government regulators and academics over the chemical’s effects, the CLARITY-BPA collaboration instead highlights divisions.
Questions Raised About “Breakthrough” Therapies’ Clinical Support
Catherine Offord | Jul 17, 2018 | 2 min read
Compared to other drugs, therapeutics given breakthrough status receive FDA approval on the basis of weaker trial evidence, a study finds.
FDA Approves First Marijuana-Derived Drug
Shawna Williams | Jun 25, 2018 | 2 min read
As the CBD-based medication enters the market, the agency promises a crackdown on producers of cannabidiol products that make unproven claims.
ADVERTISEMENT